Definitek, Inc.
Sunnyvale, CA, US· latest recorded location
Definitek, Inc. is named on 4 US grants and 4 published applications in this corpus. Its most frequent classification is G01N (Investigating or analysing materials by determining their chemical or physical properties).
- Granted patents
- 4
- Published applications
- 4
- Inventors
- 3
- Granted in 2026 so far
- 0
- Most recent grant
- 30 Jan 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 1 | 0 |
By publication year.
Technology areas
Share of 8 documents
Recent patents
- Accurate measurement of glutathione for disease diagnosis and drug metabolite screening30 Jan 2024US 11,885,821 B2
- Quantification of previously undetectable quantities15 Aug 2023US 11,728,147 B2
- Accurate measurement of glutathione for disease diagnosis and drug metabolite screening30 Mar 2021US 10,962,556 B2
- Accurate measurement of glutathione for disease diagnosis and drug metabolite screening16 Jan 2018US 9,869,684 B2
- Quantification of previously undetectable quantities12 May 2022US 2022/0148868 A1
- Accurate Measurement of Glutathione for Disease Diagnosis and Drug Metabolite Screening14 Oct 2021US 2021/0318339 A1
- Accurate measurement of glutathione for disease diagnosis and drug metabolite screening18 Oct 2018US 2018/0299471 A1
- Accurate Measurement of glutathione for disease diagnosis and drug metabolite screening20 Jun 2013US 2013/0158886 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.